Isabella Syring-Schmandke, MD, PhD
Isabella Syring-Schmandke, MD, PhD is a highly qualified and experienced specialist in urology. She specializes in endourological procedures such as the minimally invasive treatment of benign prostate enlargement and bladder tumours as well as the surgical removal of ureteral and kidney stones. In addition, Priv.-Doz. Dr. Syring-Schmandke is distinguished by her outstanding expertise in the diagnosis and treatment of urological tumors, in particular prostate cancer. As part of her doctorate and habilitation, she has also written numerous scientific publications and congress presentations, which underline her comprehensive expertise and have been honored with awards. With her extensive experience and commitment to urological research and patient care, PD Dr. med. Isabella Syring-Schmandke is a valuable asset to the Department and Practice of Urology and Special Urological Surgery.
Training
- Specialist for Urology, West German Prostate Center, KLINIK am RING, Cologne
- Specialist for Urology, Department of Urology, KLINIK am RING, Cologne
- Senior Physician for Urology, Clinic and Polyclinic for Urology and Pediatric Urology, Bonn University Hospital
- Specialist for Urology, Clinic and Polyclinic for Urology and Pediatric Urology at Bonn University Hospital
- Scholarship holder of the “Ferdinand-Eisenberger Research Scholarship” of the German Society of Urology; Department of Prostate Cancer Research, Institute of Pathology, University Hospital Bonn
- Assistant physician, Clinic and Polyclinic for Urology and Pediatric Urology, University Hospital Bonn
- Studied medicine at the Rheinische Friedrich-Wilhelms-Universität Bonn
Degrees
- Habilitation (Priv.-Doz.) on the topic “The role of the mediator complex in urological carcinomas”
- Additional qualification in “Drug-based tumor therapy”
- Fellow of the European Board of Urology (F.E.B.U.)
- Specialist in urology - North Rhine Medical Association, Düsseldorf
- Doctorate (Dr.med.) on the subject of “Experimental study on the tendency of uncoated and amorphous carbon-coated ureteral stents to incrust under the influence of albumin in artificial urine”, Clinic and Polyclinic for Urology and Pediatric Urology at the University Hospital Bonn
- Medical state examination, Rheinische Friedrich-Wilhelms-University Bonn